latanoprost punctal plug delivery system (L-PPDS)
/ Mati Therap
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
January 20, 2026
Near-Infrared Broadband Absorbing Polymer Acceptors for Flexible All-Polymer Photodetectors with High Detectivity.
(PubMed, ACS Appl Mater Interfaces)
- "Compared to conventional inorganic detectors, all-polymer photodetectors (all-PPDs) have attracted significant attention in the field of flexible and wearable electronics owing to their unique mechanical properties...Moreover, it demonstrated a low dark current density (5.5 × 10-11 A·cm-2), a wide linear dynamic range (109.0 dB), and a fast response time (rise time/fall time = 2.12/3.59 μs), outperforming many existing acceptor materials. Benefiting from the excellent mechanical properties of the all-polymer blend film, P1-TT can be used to fabricate flexible device, and it also delivered a superior detectivity of 3.3 × 1013 Jones at 700 nm under a bias of -0.1 V. Practical application tests further verified its potential in optical communications, infrared signal detection, and biometric monitoring, demonstrating its promise for use in next-generation flexible optoelectronic systems."
Journal
March 22, 2016
Assessment of age-related eye morphology and aqueous humor flow dynamics in the DBA/2J mouse model of pigmentary glaucoma using ocular MRI and anterior chamber iPerfusion systems
(ARVO 2016)
- "...9-mo DBA animals showed a decrease in Gd accumulation (Diff 10.33 ± 2.779, p<0.01) and peak Gd intensity. Facility in DBA2J shows an average of 46% reduction from 9 to 6 mo (N=4)."
Preclinical • Glaucoma • Ophthalmology
September 30, 2016
Comparison of Latanoprost PPDS With Timolol Maleate GFS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
(clinicaltrials.gov)
- P2; N=86; Active, not recruiting; Sponsor: Mati Therapeutics Inc.; Completed ➔ Active, not recruiting; Trial primary completion date: Jul 2016 ➔ Dec 2016
Enrollment closed • Trial primary completion date • Biosimilar • Cardiovascular • Glaucoma • Ophthalmology
March 23, 2016
Long-term safety and intraocular pressure lowering efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: the JUPITER study
(ARVO 2016)
- P3, N=130; JUPITER (NCT01895972); "Results from this 1-year study demonstrate that LBN 0.024% qPM was safe and well tolerated and provided robust and sustained long-term IOP lowering in Japanese subjects with OAG or OHT."
P3 data • Glaucoma • Ophthalmology
March 26, 2019
High Performance All-Polymer Photodetectors via Thick Photoactive Layer Strategy.
(PubMed, ACS Appl Mater Interfaces)
- "More importantly, the resultant all-PPDs exhibited a high working frequency over 10 kHz associated with a large linear dynamic range. These findings demonstrate the great potential for practical applications of the all-PPDs developed in this work."
Journal
1 to 5
Of
5
Go to page
1